Low-Dose Baricitinib and Danazol Combination Shows Promise in Primary ITP
Viral science news reported a new trial aimed at improving outcomes for people living with primary immune thrombocytopenia (ITP), a ...
Viral science news reported a new trial aimed at improving outcomes for people living with primary immune thrombocytopenia (ITP), a ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine